Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.

Concern has been raised that the risk of venous thromboembolism (VTE) in users of the ORTHO EVRA patch is higher compared to users of oral contraceptives (OCs).
We identified idiopathic cases of VTE and controls, matched on age and index date, from among women in the United States PharMetrics/IMS and MarketScan databases who were current users of the patch or levonorgestrel-containing OCs with 30 mcg of ethinyl estradiol. We calculated odds ratios (ORs) and 95% confidence intervals (CIs).
The ORs (95% CI) for VTE in users of the patch compared to levonorgestrel-containing OCs were 2.0 (0.9-4.1) and 1.3 (0.8-2.1) in the PharMetrics and MarketScan databases, respectively. ORs (95% CI) restricted to women aged 39 years or younger were 1.4 (0.6-3.0) and 1.2 (0.7-2.0), respectively.
These results provide evidence that the risk of idiopathic VTE in users of the patch is not materially different than that of users of levonorgestrel-containing OCs in women aged 39 years or younger. We cannot rule out some increase in the risk in women aged 40 years or older.
AuthorsSusan S Jick, Katrina W Hagberg, Rohini K Hernandez, James A Kaye
JournalContraception (Contraception) Vol. 81 Issue 1 Pg. 16-21 (Jan 2010) ISSN: 1879-0518 [Electronic] United States
PMID20004268 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contraceptives, Oral
  • Ortho Evra
  • Norgestrel
  • Ethinyl Estradiol
  • Levonorgestrel
  • Adolescent
  • Adult
  • Case-Control Studies
  • Confidence Intervals
  • Contraceptives, Oral (adverse effects)
  • Databases, Factual (statistics & numerical data)
  • Ethinyl Estradiol (adverse effects)
  • Female
  • Humans
  • Incidence
  • Levonorgestrel (adverse effects)
  • Norgestrel (adverse effects, analogs & derivatives)
  • Odds Ratio
  • Product Surveillance, Postmarketing
  • United States
  • Venous Thromboembolism (epidemiology, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: